These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10191682)

  • 21. Myocardial infarction in saphenous percutaneous intervention: are we really doing our best?
    Lozano I; Rondan J; Avanzas P
    Am Heart J; 2009 Sep; 158(3):e39; author reply e41. PubMed ID: 19699850
    [No Abstract]   [Full Text] [Related]  

  • 22. Percutaneous treatment of diseased saphenous vein grafts: current state-of-the-art and future directions.
    Vermeersch P; Agostoni P
    Minerva Cardioangiol; 2007 Oct; 55(5):637-46. PubMed ID: 17912167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment alternatives for chronically occluded saphenous vein grafts.
    Heuser RR
    J Invasive Cardiol; 1995 May; 7(4):94-6. PubMed ID: 10158110
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel use for a distal embolic protection device: stent retrieval.
    Guigauri P; Dauerman HL
    J Invasive Cardiol; 2005 Mar; 17(3):183-4. PubMed ID: 15867454
    [No Abstract]   [Full Text] [Related]  

  • 25. Should bare metal or drug-eluting stents be used during PCI of saphenous vein graft lesions: waiting for Godot?
    Brilakis ES; Berger PB
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):815-8. PubMed ID: 19006238
    [No Abstract]   [Full Text] [Related]  

  • 26. Totally occluded saphenous vein graft recanalization: a dangerous option.
    Londero HF
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):218-20. PubMed ID: 14517928
    [No Abstract]   [Full Text] [Related]  

  • 27. Intragraft nicardipine prophylaxis to prevent no-reflow in triple-vessel saphenous vein graft intervention.
    Fischell T; Haller S; Ashraf K
    J Invasive Cardiol; 2005 Jun; 17(6):334-7. PubMed ID: 16003012
    [No Abstract]   [Full Text] [Related]  

  • 28. Current status of plain old balloon angioplasty.
    Deshpande NV; Serruys PW
    Indian Heart J; 1998 Oct; 50 Suppl 1():5-13. PubMed ID: 9824902
    [No Abstract]   [Full Text] [Related]  

  • 29. Percutaneous management of a saphenous venous graft leaking pseudoaneurysm.
    Devarapalli S; Cline S; Kalaria VG
    J Invasive Cardiol; 2005 Mar; 17(3):187-8. PubMed ID: 15867456
    [No Abstract]   [Full Text] [Related]  

  • 30. The unrelenting challenge of vein graft disease.
    Hermiller JB
    J Invasive Cardiol; 2010 Jun; 22(6):258-9. PubMed ID: 20516503
    [No Abstract]   [Full Text] [Related]  

  • 31. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial.
    Mauri L; Cox D; Hermiller J; Massaro J; Wahr J; Tay SW; Jonas M; Popma JJ; Pavliska J; Wahr D; Rogers C
    J Am Coll Cardiol; 2007 Oct; 50(15):1442-9. PubMed ID: 17919563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DES for SVG stenosis -- we all want to do it, but are we there yet?
    Smith CS; Yeghiazarians Y
    J Invasive Cardiol; 2007 Oct; 19(10):410-1. PubMed ID: 17906341
    [No Abstract]   [Full Text] [Related]  

  • 33. Contemporary management of vein graft disease.
    Hermiller J
    J Invasive Cardiol; 2005 Aug; 17(8):399-400. PubMed ID: 16079442
    [No Abstract]   [Full Text] [Related]  

  • 34. Percutaneous saphenectomy: a potentially dreadful complication of cutting balloon angioplasty in saphenous vein grafts.
    Tassanawiwat W; Biondi-Zoccai GG; Sangiorgi G; Iakovou I; Tsagalou E; Melzi G; Ge L; Morici N; Corvaja N; Colombo A
    Int J Cardiol; 2006 Jan; 106(3):418-9. PubMed ID: 16337059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of adjunctive treatment with tirofiban on troponin T elevation during stenting of critically stenosed aortocoronary saphenous vein grafts.
    Kurowski V; Toelg R; Jain D; Richter C; Wiegand UK; Richardt G; Khattab AA
    Am J Cardiol; 2005 Sep; 96(5):681-4. PubMed ID: 16125495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stent in saphenous vein graft lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
    [No Abstract]   [Full Text] [Related]  

  • 37. Stenting for saphenous vein graft disease: have we solved the problem?
    Chauhan MS; Carrozza JP
    J Invasive Cardiol; 2000 Oct; 12(10):513-5. PubMed ID: 11022210
    [No Abstract]   [Full Text] [Related]  

  • 38. The clinical impact of atherosclerotic saphenous vein to coronary artery bypass grafts.
    Lytle BW
    Semin Thorac Cardiovasc Surg; 1994 Apr; 6(2):81-6. PubMed ID: 8025142
    [No Abstract]   [Full Text] [Related]  

  • 39. Do we still need distal protection in the treatment of SVG disease?
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):804-5. PubMed ID: 19009627
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of angioscopy on coronary interventions.
    White CJ; Ramee SR; Collins TJ; Jenkins JS
    Indian Heart J; 1998 Oct; 50 Suppl 1():89-98. PubMed ID: 9824913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.